“If we want to preserve this protection model, we must mobilize all the levers”, assures Thomas Fatome, Managing Director of the CNAM

Health insurance expects to see its deficit reaching 41 billion euros in 2030. The organization gave avenues of work to straighten the accounts. Its managing director suggests in particular to focus on prevention.

“If we want to preserve this protection model, we must mobilize all the levers”, Ensures Wednesday, June 25, Thomas Fatome, Managing Director of the National Health Insurance Fund, invited to the phone rings on France Inter. Health insurance made 60 proposals, in its annual report on Tuesday June 24, to reduce its deficit which could reach 16 billion euros in 2025 and 41 billion euros in 2030.

Among the proposals, there is “Fight against fraud” And the “prescriptions which are abusive”, especially in the stopades. “We are in the process of launching a control campaign of around 500 doctors who are very large prescribers of work stoppages, who prescribe two to three times more stop than their colleagues with equivalent patients”explains Thomas Fatome, who recalls that this only concerns only “500 doctors out of 50,000” generalists.

Another proposal at the heart of the report: prevention. “We can do better around the screening for cardiovascular diseases”concedes the director of the CNAM, especially on the issues “Around hypertension, which is one of the main chronic diseases of our country”. So you have to do “much more systematic screening policies”, Quoting the English example of the campaign “Know Your Numbers”, knowingR “Know your numbers” of health markers.

“We really think that with pharmacists, we can build something, in connection with doctors, in connection with nurses, so that these hypertension screenings are much more frequent, much more systematic”insists Thomas Fatome.

Thermal cures are also in the viewfinder of health insurance proposals. “Our proposal is not to unrepise thermal cures, because it is an important subject”he specifies, but “The scientific efficiency of thermal cures is debated” And he therefore wonders “To justify going up to 100%” in reimbursement. “This question can exist for thermal treatment, but it can potentially exist for other drugs when their medical utility is questioned”he details. “I think it’s a debate that we can have calmly”.

He recalls that inflation and covid have hit the accounts of the health organization harshly. But that “What is most worrying is the fact that aging and chronic pathologies will weigh more and more on health insurance finances” and that therefore“If we want to preserve this protection model, we must mobilize all the levers” Financiers.